Podcast · 4 episodes in the reference, 2020 to 2024
Published by Samir Kaji
| Khosla Venture's Samir Kaul on building an iconic, durable firm, and the role of non-consensus decision making | Samir Kaul | 16 February 2024 | Follow me @samirkaji for my thoughts on the venture market, with a focus on the continued evolution of the VC landscape. We have a conversation with Samir Kaul from Khosla Ventures . Founded in 2004, Khosla is one of the largest and most well-known venture capital firms in the world and led by legendary investor and entrepreneur Vinod Khosla . The firm is known for investing in companies that are solving very large and complex problems. The firm currently has over $15B in AUM investing in companies such as Square, Doordash, Stripe, OpenAI, and Impossible Foods. During the episode, we covered investing across cycles, the market insanity we saw pre-2022, and how they approach both building a firm and investing. Note: We recorded this prior to the news that Keith Rabois was rejoining the firm, hence no mention of it during the discussion. About Samir Kaul: Samir Kaul is a Founding Partner and Managing Director at Khosla Ventures, and he specializes in investments across health, sustainability, food, and advanced technology sectors. His notable investments leading to successful exits through IPOs or acquisitions include companies like Vicarious Surgical, View, Guardant Health, Nutanix, Oscar, Quantumscape, Granular, SLD, NanoH2O, Iora Health, and Raxium. | |
| Going back to the foundation of Kleiner Perkins with Mamoon Hamid through clear busines model focus and culture | Mamoon Hamid | 1 November 2023 | Follow me @samirkaji for my thoughts on the venture market, with a focus on the continued evolution of the VC landscape. We are excited to bring you our latest episode with Mamoon Hamid , Partner at Kleiner Perkins . As many know, Kleiner Perkins, founded over 50 years ago is one of the most storied franchises in the history of venture capital, having backed companies companies such as Genentech, Sun Microsystems, Amazon, Google, and Uber. After stints at USVP and Social Capital (which he co-founded), Mamoon joined Kleiner in 2017 as part of a generational succession process. As part of this, Mamoon has focused heavily on returning Kleiner to the roots of it’s history as a premier boutique venture capital fund focused on early-stage investing. Since then, they’ve backed companies such as Rippling and Figma. Mamoon and I spoke about how he and the team have executed the mission of bringing Kleiner to what they have coined as going back to the future. We covered a number of topics but dug deep into the importance of culture and focus. About Mamoon Hamid: Mamoon Hamid is a Partner at Kleiner Perkins. He has been an early investor in and served on the boards of some of the most innovative software companies of recent times including Slack, Figma, Box and Rippling. Prior to joining Kleiner Perkins, Mamoon was a co-founder of Social Capital. He started his venture career in 2005 at U.S. Venture Partners (USVP) where he eventually became Partner. | |
| Deena Shakir of Lux Capital on firm culture, solving the diversity issue, and how portfolio management is a team sport - Venture Unlocked 014 | Deena Shakir | 22 December 2020 | Deena Shakir is a General Partner at Lux Capital , a firm founded in 2000 and has since raised $2.5 billion. Lux invests in emerging science and deep technology startups such as Auris Health, Cerulean, Zoox, and Bright Machines. Deena graduated from Harvard undergrad and began her career as a presidential management fellow at the US Department of State, where she built partnerships with tech companies and helped launch President Obama’s global entrepreneurship summit in 2010. She then joined Google, where she led business development and strategic partnerships for their global civic innovation portfolio before shifting to the investment side at Google Ventures (GV). In 2019 Deena joined Lux Capital and focuses on companies that are seeking to provide solutions to improve human & environmental health, and productivity. We covered several topics on the show, including: 01:12- Deena’s background as the daughter of Iraqi immigrants in California and her early career in journalism and government 08:17 - What prompted her move to GV to Lux 12:35 - What is the behavior trait that drives Lux as a firm 16:39 - How Lux makes decisions as a partnership 18:30 - Why portfolio management is a team sport at Lux. 22:12 - Establishing a company culture and hiring employees that will fit within it. 25:46 - What growth in fund size means in dictating strategy and mindset. | |
| Chris Douvos of Ahoy Capital on the art of investing in Emerging VC funds, Venture Unlocked 013 | Josh Kopelman | 15 December 2020 | For daily thoughts on the venture landscape, follow me @samirkaji on Twitter. Chris Douvos is the Founder of Ahoy Capital , a boutique Fund of Funds that focuses primarily on allocating into early-stage venture capital funds, while selectively co-investing directly into companies. Chris started his career at Morgan Stanley while still at Yale earning his MBA. From there he worked at Princeton University’s endowment fund where he got his start in venture before moving onto The Investment Fund for Foundations (TIFF). At TIFF he decided that the right strategy was to make “heroic investments” and invest in very early stage, and often unproven managers. This method paid off as Chris was one of the first institutional Limited Partners to back First Round Capital (and remains so). Chris then went on to Venture Investment Associates (VIA) prior to spinning out to start Ahoy Capital in 2018. Ever engaging, Chris covers a whole host of emerging VC topics and he and I discuss the following: 6:20 Why Chris started a fund that invests in emerging managers and how he’s arbitraging people’s inattention to get to true outsized returns. 9:00 The process for raising a FoF, and what his LP’s are looking for. 10:59 Ahoy’s portfolio model on managers, and why he thinks concentration is the right avenue for them. 11:54 Why looking at past performance shouldn’t always be the leading indicator in evaluating firms, and why he looks at other specific factors. |